Goldman Sachs

New Business

Opinion | Effects of Trump’s tariffs in the US paint a less than pretty picture

US President Donald Trump’s tariffs on imported goods such as wood, furniture and cabinets have recently gone into effect, marking…

Read More »
New Business

China’s new home prices slump at fastest pace in 11 months amid dented buyer confidence

China’s new home prices fell at the fastest pace in 11 months in September across 70 major cities despite easing…

Read More »
New Business

Silver hits record high, surging past US$52 amid historic London short squeeze

Silver prices touched an all-time high above US$52.50 an ounce, as a historic short squeeze in London added momentum to…

Read More »
New Business

China’s property managers pivot to elderly services and pet care amid real estate woes

China’s years-long real estate downturn is slowing growth and forcing China’s property managers to look for new sources of income,…

Read More »
New Business

Soaring valuations among China’s sizzling chip, AI-related stocks test investors’ patience

China’s chip stocks have staged a world-beating rally in the past few months on the nation’s self-sufficiency push, but some…

Read More »
New Business

Exclusive | Hong Kong as good as Wall Street for Chinese tech firms, Goldman Sachs banker says

In the Capital Connectors series, exclusive interviews with six influential Chinese and global bankers reveal the opportunities and challenges for…

Read More »
New Business

China’s central bank aids gold’s record-setting run with 11-month buying streak

Even after a record-setting run, the price of gold appears poised for further gains, as China’s central bank extended its…

Read More »
New Business

Exclusive | International firms flock to Hong Kong, signalling rebound for city’s capital market

In the Capital Connectors series, exclusive interviews with six influential Chinese and global bankers reveal the opportunities and challenges for…

Read More »
New Business

China rate cuts likely in fourth quarter amid growth concerns: Goldman Sachs

China’s central bank appears increasingly likely to ease its monetary stance in the fourth quarter, according to Goldman Sachs, as…

Read More »
New Business

Ascletis Pharma trial shows drug candidate ASC47 boosts weight loss effect of semaglutide

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…

Read More »
Back to top button